| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Hyunji Lee | |
| Jisoo Park | |||
| Jongsun Park | |||
| Quangdon Tran | |||
| Chaeyeong Kim | |||
| Gyeyeong Kong | |||
| P2860 | cites work | Ontogeny of adipokine expression in neonatal pig adipose tissue | Q79638932 |
| Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association | Q79792677 | ||
| Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease | Q83334952 | ||
| Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice | Q83396025 | ||
| Ginsenoside Rg3 inhibits colon cancer cell migration by suppressing nuclear factor kappa B activity | Q86351275 | ||
| Fat accumulation and obesity-related cardiovascular risk factors in middle-aged Japanese men and women | Q87299567 | ||
| Update on the American Diabetes Association Standards of Medical Care | Q88184700 | ||
| Resistin Levels in Non-alcoholic Fatty Liver Disease Pathogenesis | Q88241247 | ||
| [Biocatalytic strategies in producing ginsenoside by glycosidase-a review] | Q90323669 | ||
| Ginsenoside Rb1 and mitochondria: A short review of the literature | Q90355907 | ||
| Supervised lifestyle intervention for people with metabolic syndrome improves outcomes and reduces individual risk factors of metabolic syndrome: A systematic review and meta-analysis | Q91042274 | ||
| Combined Amelioration of Ginsenoside (Rg1, Rb1, and Rg3)-enriched Korean Red Ginseng and Probiotic Lactobacillus on Non-alcoholic Fatty Liver Disease | Q92261635 | ||
| Stereoselective Anti-Cancer Activities of Ginsenoside Rg3 on Triple Negative Breast Cancer Cell Models | Q92373348 | ||
| Obesity and cancer risk: recent review and evidence | Q22252595 | ||
| Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance | Q28131660 | ||
| Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease | Q28282463 | ||
| Standards of medical care in diabetes--2014 | Q28304435 | ||
| Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature | Q28354330 | ||
| Biosynthesis and biotechnological production of ginsenosides | Q29013165 | ||
| Prevalence of childhood and adult obesity in the United States, 2011-2012 | Q29547370 | ||
| Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function | Q29616104 | ||
| Molecular mediators of hepatic steatosis and liver injury | Q29616709 | ||
| Overview of the metabolic syndrome; an emerging pandemic of public health significance. | Q30366107 | ||
| Metabolic syndrome pandemic. | Q30366941 | ||
| The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus | Q30379006 | ||
| The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: II. Therapeutic management of atherogenic dyslipidemia. | Q30380628 | ||
| Pathogenesis of non-alcoholic fatty liver disease. | Q33606303 | ||
| Pharmacokinetic Comparison of 20(R)- and 20(S)-Ginsenoside Rh1 and 20(R)- and 20(S)-Ginsenoside Rg3 in Rat Plasma following Oral Administration of Radix Ginseng Rubra and Sheng-Mai-San Extracts | Q33768107 | ||
| Obesity and diabetes. | Q33889941 | ||
| 20(S)-Ginsenoside Rg3 is a novel inhibitor of autophagy and sensitizes hepatocellular carcinoma to doxorubicin | Q34101000 | ||
| Obesity and severe obesity forecasts through 2030. | Q34275955 | ||
| A prospective study of obesity and risk of coronary heart disease among diabetic women | Q34711103 | ||
| Role of cytokines in the pathogenesis of non-alcoholic Fatty liver disease | Q35022435 | ||
| Review article: Non-alcoholic fatty liver disease | Q35106643 | ||
| Current best treatment for non-alcoholic fatty liver disease | Q35124679 | ||
| Effect of oral inulin administration on lipid profile and insulin sensitivity in subjects with obesity and dyslipidemia | Q44564618 | ||
| Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention | Q45067817 | ||
| Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats | Q45219805 | ||
| Hypoglycemic effects of malonyl-ginsenosides extracted from roots of Panax ginseng on streptozotocin-induced diabetic mice | Q46092304 | ||
| Studies on absorption, distribution and metabolism of ginseng in humans after oral administration | Q46161215 | ||
| Therapeutic potential of 20(S)-ginsenoside Rg(3) against streptozotocin-induced diabetic renal damage in rats | Q46494850 | ||
| Ginsenoside Rh1: A Systematic Review of Its Pharmacological Properties. | Q47735141 | ||
| High genetic risk scores for impaired insulin secretory capacity doubles the risk for type 2 diabetes in Asians and is exacerbated by Western-type diets. | Q48162160 | ||
| Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice | Q48630964 | ||
| Effect of Rg3-enriched Korean red ginseng (Panax ginseng) on arterial stiffness and blood pressure in healthy individuals: a randomized controlled trial. | Q50466760 | ||
| Korean red ginseng (Panax ginseng) prevents obesity by inhibiting angiogenesis in high fat diet-induced obese C57BL/6J mice. | Q50499018 | ||
| Natural course of nonalcoholic fatty liver disease in southern China: a prospective cohort study. | Q51179884 | ||
| Abdominal fat distribution and metabolic risk factors: effects of race. | Q51579989 | ||
| The Global Epidemic of the Metabolic Syndrome. | Q52685620 | ||
| Inhibition of Osteoclast Differentiation by Ginsenoside Rg3 in RAW264.7 Cells via RANKL, JNK and p38 MAPK Pathways Through a Modulation of Cathepsin K: An In Silico and In Vitro Study. | Q53838927 | ||
| Rg3-enriched Korean Red Ginseng enhances blood pressure stability in spontaneously hypertensive rats. | Q54614382 | ||
| Non-alcoholic fatty liver disease: the problems we are facing | Q35576566 | ||
| Abdominal obesity: a marker of ectopic fat accumulation | Q35720154 | ||
| Cancer prevention and therapeutics: Panax ginseng. | Q35896682 | ||
| Ginsenoside Rg3 Serves as an Adjuvant Chemotherapeutic Agent and VEGF Inhibitor in the Treatment of Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review. | Q36178907 | ||
| Pathogenesis and management issues for non-alcoholic fatty liver disease | Q36179902 | ||
| New insights in the pathogenesis of non-alcoholic fatty liver disease | Q36470867 | ||
| Is insulin resistance atherogenic? Possible mechanisms | Q36525077 | ||
| Is insulin resistance atherogenic? A review of the evidence | Q36529246 | ||
| Age-dependent Distribution of Fungal Endophytes in Panax ginseng Roots Cultivated in Korea | Q36861137 | ||
| Characterizing a full spectrum of physico-chemical properties of (20S)- and (20R)-ginsenoside Rg3 to be proposed as standard reference materials | Q36861250 | ||
| Metabolic implications of body fat distribution | Q36923359 | ||
| Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
| Non-alcoholic fatty liver disease pathogenesis: the present and the future | Q37395200 | ||
| Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome | Q37580095 | ||
| A systematic review and meta-analysis of Ginsenoside-Rg1 (G-Rg1) in experimental ischemic stroke | Q37736328 | ||
| Ginsenoside Re: pharmacological effects on cardiovascular system | Q37925017 | ||
| Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease | Q37940917 | ||
| Body fat distribution in females: metabolic consequences and implications for weight loss. | Q37945508 | ||
| Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD. | Q38083805 | ||
| Prevalence of metabolic syndrome and metabolic syndrome components in young adults: A pooled analysis | Q38631346 | ||
| Metabolic syndrome update | Q38665336 | ||
| Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease | Q38803859 | ||
| Ginsenoside Rg3 regulates S-nitrosylation of the NLRP3 inflammasome via suppression of iNOS. | Q38862750 | ||
| Anticancer effects of ginsenoside Rg3 (Review). | Q39093587 | ||
| Hepataprotective effects of ginsenoside Rg1 - A review | Q39253237 | ||
| Antioxidative, anti-inflammatory, and matrix metalloproteinase inhibitory activities of 20(S)-ginsenoside Rg3 in cultured mammalian cell lines | Q39262209 | ||
| Stereoisomers ginsenosides-20(S)-Rg₃ and -20(R)-Rg₃ differentially induce angiogenesis through peroxisome proliferator-activated receptor-gamma. | Q39665836 | ||
| Regional adiposity and morbidity | Q40638635 | ||
| Antihypertensive effect of Korean Red Ginseng by enrichment of ginsenoside Rg3 and arginine-fructose | Q40978434 | ||
| Therapeutic potential of heat-processed Panax ginseng with respect to oxidative tissue damage. | Q42718886 | ||
| Ginsenoside Rg3 ameliorated HFD-induced hepatic steatosis through downregulation of STAT5-PPARγ. | Q42795948 | ||
| Anti-obesity effect of sulfated glucosamine by AMPK signal pathway in 3T3-L1 adipocytes | Q42798303 | ||
| Antiobesity effect of ginsenoside Rg3 involves the AMPK and PPAR-gamma signal pathways | Q42807692 | ||
| Effect of ginsenosides Rg3 and Re on glucose transport in mature 3T3-L1 adipocytes | Q42811385 | ||
| Identification of nesfatin-1 in human and murine adipose tissue: a novel depot-specific adipokine with increased levels in obesity | Q42827198 | ||
| Insulin effects on sterol regulatory-element-binding protein-1c (SREBP-1c) transcriptional activity in rat hepatocytes. | Q42997321 | ||
| Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease | Q43247804 | ||
| Studies on Absorption, Distribution, Excretion and Metabolism of Ginseng Saponins. VII. Comparison of the Decomposition Modes of Ginsenoside-Rb1 and -Rb2 in the Digestive Tract of Rats | Q43712529 | ||
| Apolipoprotein synthesis in nonalcoholic steatohepatitis | Q43933950 | ||
| Sterol regulatory element binding protein-1c expression and action in rat muscles: insulin-like effects on the control of glycolytic and lipogenic enzymes and UCP3 gene expression | Q44007196 | ||
| [Potential distribution of Panax ginseng and its predicted responses to climate change.] | Q57094091 | ||
| Type 2 diabetes mellitus | Q58447602 | ||
| Protective effects of enhanced minor ginsenosides in Lactobacillus fermentum KP-3-fermented ginseng in mice fed a high fat diet | Q58606874 | ||
| Adiponectin in Obesity-Associated Colon Cancer and Its Preventive Implications: Comment on "Association of Visceral Fat Accumulation and Adiponectin Levels with Colorectal Neoplasia" | Q59328454 | ||
| A new role for the ginsenoside RG3 in antiaging via mitochondria function in ultraviolet-irradiated human dermal fibroblasts | Q61764517 | ||
| High-throughput metabolomics and ingenuity pathway approach reveals the pharmacological effect and targets of Ginsenoside Rg1 in Alzheimer's disease mice | Q64064578 | ||
| Ginsenoside Rg3: Potential Molecular Targets and Therapeutic Indication in Metastatic Breast Cancer | Q64232160 | ||
| Saponin from sea cucumber exhibited more significant effects than ginsenoside on ameliorating high fat diet-induced obesity in C57BL/6 mice. | Q64935638 | ||
| Pharmacological study on Panax ginseng C. A. Meyer. IV. Effects of red ginseng on experimental disseminated intravascular coagulation. (3). Effect of ginsenoside-Ro on the blood coagulative and fibrinolytic system | Q69588008 | ||
| Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VI. The decomposition products of ginsenoside Rb2 in the stomach of rats | Q70197994 | ||
| Studies on absorption, distribution, excretion and metabolism of ginseng saponins. V. The decomposition products of ginsenoside Rb2 in the large intestine of rats | Q70244493 | ||
| Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. I. Quantitative analysis of ginsenoside Rg1 in rats | Q70475660 | ||
| Studies on the absorption, distribution, excretion and metabolism of ginseng saponins. II. The absorption, distribution and excretion of ginsenoside Rg1 in the rat | Q71734147 | ||
| Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis | Q73735584 | ||
| Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations | Q74732565 | ||
| Obesity and dyslipidemia | Q75229764 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | metabolic syndrome | Q657193 |
| P304 | page(s) | 130 | |
| P577 | publication date | 2020-02-25 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | Relationship Between Ginsenoside Rg3 and Metabolic Syndrome | |
| P478 | volume | 11 |
Search more.